
ProgenyHealth Secures Growth Investment from Cressey & Sunstone Partners
ProgenyHealth has announced a significant growth investment from its existing investor, Sunstone Partners, and new partner, Cressey & Company, announced in a press release. This investment aims to support the expansion of ProgenyHealth's services, enhancing maternal and infant health care across the United States.
Sunstone Partners, which initially invested in ProgenyHealth in 2017, has seen the company quadruple its business and manage 140,000 NICU births since then. Cressey & Company, a private investment firm specializing in healthcare services, will provide additional resources and expertise to accelerate ProgenyHealth's growth and performance.
ProgenyHealth, founded in 2003, is recognized for its comprehensive maternity and NICU care management services. The company collaborates with health plans, physicians, and families to improve clinical outcomes and reduce healthcare costs. With this new investment, ProgenyHealth aims to further expand its reach and impact in the healthcare sector.
We hope you enjoyed this article.
Consider subscribing to one of several newsletters we publish like Life AI Weekly.
Also, consider following us on social media:
More from: Healthcare & Life Sciences
Subscribe to Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Market report
2025 Generative AI in Professional Services Report
This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.
Read more